Novel screening agar for detection of vancomycin-nonsusceptible Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 949-951

  Burnham, Carey Ann D ^a   Weber, Carol J ^b   Dunne Jr , W Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM ISOLATE; DISK DIFFUSION; INFUSION SYSTEM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AGAR; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; HUMANS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77749340442     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02295-09     Document Type: Article

References (10)

1. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests: approved standard, 9th ed. CLSI document M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19, 19th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Kosowska-Shick, K., L. M. Ednie, P. McGhee, K. Smith, C. D. Todd, A. Wehler, and P. C. Appelbaum. 2008. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Antimicrob. Agents Chemother. 52:4510-4513.
6. Mason, E. O., L. B. Lamberth, W. A. Hammerman, K. G. Hulten, J. Versalovic, and S. L. Kaplan. 2009. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J. Clin. Microbiol. 47:1628-1630.
7. Swenson, J. M., K. F. Anderson, D. R. Lonsway, A. Thompson, S. K. Mc-Allister, B. M. Limbago, R. B. Carey, F. C. Tenover, and J. B. Patel. 2009. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J. Clin. Microbiol. 47:2013-2017.
8. Swenson, J. M., J. B. Patel, and J. H. Jorgensen. 2007. Special phenotypic methods for detecting antibacterial resistance, p. 1173-1192. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
9. Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O'Hara, S. K. McAllister, N. C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
10. Tenover, F. C., and R. C. Moellering, Jr. 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 44:1208-1215.